| 21.13 Data as of May 21 |  -0.11 / -0.52%Today’s Change | 10.26 Today|||52-Week Range 21.69 | +55.48% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Skyler Jay S Director |  Buy | 3/11/2013 | 70,000 | $15.50 | $1.1M | +35.71% |
Balo Andrew K Senior VP-Regulatory & Clinical Affairs |  Sale | 5/13/2013 | 45,000 | $19.40 | $873.0K | +6.07% |
Pacelli Steven R EVP-Strategy & Corporate Development | Sale | 2/26/2013 | 30,000 | $14.95 | $448.5K | +40.68% |
Pacelli Steven R EVP-Strategy & Corporate Development | Sale | 2/28/2013 | 25,000 | $14.99 | $374.8K | +41.62% |
Valdes Jorge A Chief Technology Officer | Sale | 3/12/2013 | 21,054 | $16.31 | $343.4K | +24.37% |
Pacelli Steven R EVP-Strategy & Corporate Development | Sale | 3/13/2013 | 21,395 | $15.69 | $335.7K | +26.45% |
Valdes Jorge A Chief Technology Officer | Sale | 12/13/2012 | 22,939 | $14.00 | $321.1K | +54.91% |
Pacelli Steven R EVP-Strategy & Corporate Development | Sale | 2/27/2013 | 20,000 | $15.01 | $300.2K | +41.05% |
Moy Jeffrey C Senior Vice President-Operations | Sale | 8/15/2012 | 21,249 | $12.80 | $272.0K | +64.69% |
Balo Andrew K Senior VP-Regulatory & Clinical Affairs | Sale | 3/13/2013 | 15,416 | $16.53 | $254.8K | +26.45% |
.
